Menopause-induced 17β-estradiol and progesterone loss increases senescence markers, matrix disassembly and degeneration in mouse cartilage
- PMID: 39820791
- DOI: 10.1038/s43587-024-00773-2
Menopause-induced 17β-estradiol and progesterone loss increases senescence markers, matrix disassembly and degeneration in mouse cartilage
Abstract
Female individuals who are post-menopausal present with higher incidence of knee osteoarthritis (KOA) than male counterparts; however, the mechanisms underlying this disparity are unknown. The most commonly used preclinical models lack human-relevant menopausal phenotypes, which may contribute to our incomplete understanding of sex-specific differences in KOA pathogenesis. Here we chemically induced menopause in middle-aged (14-16 months) C57/BL6N female mice. When we mapped the trajectory of KOA over time, we found that menopause aggravated cartilage degeneration relative to non-menopause controls. Network medicine analyses revealed that loss of 17β-estradiol and progesterone with menopause enhanced susceptibility to senescence and extracellular matrix disassembly. In vivo, restoration of 17β-estradiol and progesterone in menopausal mice protected against cartilage degeneration compared to untreated menopausal controls. Accordingly, post-menopausal human chondrocytes displayed decreased markers of senescence and increased markers of chondrogenicity when cultured with 17β-estradiol and progesterone. These findings implicate menopause-associated senescence and extracellular matrix disassembly in the sex-specific pathogenesis of KOA.
© 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests: R.C.T. is a consultant and advisor for Astellas Pharma, a consultant for Bayer and on the medical advisory board at Hello Therapeutics. The other authors declare no competing interests.
References
-
- Hagyard, J. A Clinical History of Diseases. Part 2. A Clinical History of the Nodosity of the Joints (Cadell and Davies, 1805).
MeSH terms
Substances
Grants and funding
- R01AG052978/U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health)
- R01AG061005/U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health)
- P2C HD086843/HD/NICHD NIH HHS/United States
- F30AG084163/U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health)
- R01 AG089455/AG/NIA NIH HHS/United States
- F30 AG084163/AG/NIA NIH HHS/United States
- R01 AG061005/AG/NIA NIH HHS/United States
- T32AG021885/U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health)
- R01 AG052978/AG/NIA NIH HHS/United States
- KL2 TR001856/TR/NCATS NIH HHS/United States
- P2CHD086843/U.S. Department of Health & Human Services | NIH | Center for Information Technology (Center for Information Technology, National Institutes of Health)
LinkOut - more resources
Full Text Sources
Medical
